October 2021 Group Watch: Southern Research to Invest Nearly $20M in Birmingham
Southern Research has closed on the sale of its Maryland facility as part of the organization’s plan to spur investment and launch new facilities in Birmingham. The sale paves the way for the research nonprofit to invest almost $20 million in its Birmingham campus, which will bring an additional 50 jobs to Alabama. Southern Research’s founding dates back to 1941, when it was established in Birmingham. According to the nonprofit, Southern Research has involved itself in COVID-19 response since the pandemic began. The organization has directed more than $30 million in research and development on virus testing, treatment and vaccine development. Southern Research and Tonix, the organization which purchased the Maryland site, have collaborated on a COVID-19 vaccine that is currently in clinical trials. The partnership will continue as Southern Research moves forward with its work on vaccines and antivirals at its Birmingham campus. Southern Research is an independent, nonprofit scientific research organization that conducts work with its scientists and engineers across three divisions: life sciences, engineering and energy and environment.
